Antitsa Stoycheva - Concepedia

Author

Antitsa Stoycheva

WuXi AppTec (China)ORCID

Also Known As

A. Stoycheva, A.D. Stoycheva, Antitsa D. Stoycheva, Antitsa Stoycheva

Publications

Citations

H-Index

Concepts

All Affiliations

WuXi AppTec (China)The Ohio State University Rega Institute for Medical Research KU Leuven Gilead Sciences (United States)

About

Antitsa Stoycheva is an author at WuXi AppTec (China) specializing in natural sciences, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	10	10	453
2	Medicine	9	9	434
3	Biochemistry	7	7	375
4	Engineering	3	3	142
5	Applied Physics	3	3	142

Antitsa Stoycheva

Publications

Citations

H-Index

Page 1

	Year	Citations
Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227) Scott D. Seiwert, Steven W. Andrews, Yutong Jiang, Antimicrobial Agents and Chemotherapy BiochemistryViral HepatitisMedicineNatural SciencesImmunology	2008	173
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To Nirmatrelvir Dirk Jochmans, Kim Donckers, Antitsa Stoycheva, mBio	2023	163
Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate Jérôme Deval, Jin Tae Hong, Guangyi Wang, PLoS Pathogens Selective InhibitionViral ReplicationMolecular VirologyBiochemistryMedicine	2015	90
Stripe Melting in a Two-Dimensional System with Competing Interactions Antitsa Stoycheva, Sherwin J. Singer Physical Review Letters Materials ScienceEngineeringPhysicsInterfacial PhenomenonSelf-assembly	2000	86
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH) Xuan G. Luong, Sarah Stevens, Andreas Jekle, PLoS ONE	2020	66
Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-<i>C</i>-methyluridine 5′-Phosphoramidate Prodrug (<b>AL-335</b>) for the Treatment of Hepatitis C Infection Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Journal of Medicinal Chemistry	2019	46
The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor <i>in vitro</i> and confer resistance to nirmatrelvir Dirk Jochmans, Kim Donckers, Antitsa Stoycheva,	2022	44
Computer simulations of a two-dimensional system with competing interactions Antitsa Stoycheva, Sherwin J. Singer Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics EngineeringSmall Repulsion StrengthSimulationMulti-physics InteractionComputational Chemistry	2002	37
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Biochemical and Biophysical Research Communications MedicineImmunologyAntiviral Drug DevelopmentTherapeutic EfficacyVivo Efficacy	2021	37
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH Koen Vandyck, David C. McGowan, Xuan G. Luong, Journal of Medicinal Chemistry	2024	32

Page 1